Annual Operating Profit
-$378.94 M
-$143.34 M-60.84%
December 31, 2024
Summary
- As of March 13, 2025, RNA annual operating income is -$378.94 million, with the most recent change of -$143.34 million (-60.84%) on December 31, 2024.
- During the last 3 years, RNA annual operating profit has fallen by -$260.88 million (-220.99%).
- RNA annual operating profit is now -3509.60% below its all-time high of -$10.50 million, reached on December 31, 2018.
Performance
RNA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$120.99 M
-$22.86 M-23.29%
December 31, 2024
Summary
- As of March 13, 2025, RNA quarterly operating income is -$120.99 million, with the most recent change of -$22.86 million (-23.29%) on December 31, 2024.
- Over the past year, RNA quarterly operating profit has dropped by -$22.86 million (-23.29%).
- RNA quarterly operating profit is now -5465.32% below its all-time high of -$2.17 million, reached on March 31, 2019.
Performance
RNA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$378.94 M
-$54.25 M-16.71%
December 31, 2024
Summary
- As of March 13, 2025, RNA TTM operating income is -$378.94 million, with the most recent change of -$54.25 million (-16.71%) on December 31, 2024.
- Over the past year, RNA TTM operating profit has dropped by -$54.25 million (-16.71%).
- RNA TTM operating profit is now -17330.40% below its all-time high of -$2.17 million, reached on March 31, 2019.
Performance
RNA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RNA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.8% | -23.3% | -16.7% |
| 3 y3 years | -221.0% | -23.3% | -16.7% |
| 5 y5 years | -2086.3% | -23.3% | -16.7% |
RNA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -221.0% | at low | -251.1% | at low | -221.0% | at low |
| 5 y | 5-year | -2086.3% | at low | -1900.8% | at low | -2086.3% | at low |
| alltime | all time | -3509.6% | at low | -5465.3% | at low | <-9999.0% | at low |
Avidity Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$378.94 M(+60.8%) | -$120.99 M(+23.3%) | -$378.94 M(+16.7%) |
| Sep 2024 | - | -$98.13 M(+18.8%) | -$324.69 M(+13.9%) |
| Jun 2024 | - | -$82.63 M(+7.0%) | -$285.18 M(+11.8%) |
| Mar 2024 | - | -$77.19 M(+15.6%) | -$255.19 M(+8.3%) |
| Dec 2023 | -$235.60 M(+31.7%) | -$66.74 M(+13.8%) | -$235.60 M(+6.1%) |
| Sep 2023 | - | -$58.63 M(+11.4%) | -$222.08 M(+6.6%) |
| Jun 2023 | - | -$52.63 M(-8.6%) | -$208.38 M(+3.1%) |
| Mar 2023 | - | -$57.60 M(+8.2%) | -$202.05 M(+12.9%) |
| Dec 2022 | -$178.91 M(+51.6%) | -$53.23 M(+18.5%) | -$178.91 M(+8.9%) |
| Sep 2022 | - | -$44.93 M(-3.0%) | -$164.24 M(+10.5%) |
| Jun 2022 | - | -$46.30 M(+34.4%) | -$148.59 M(+15.5%) |
| Mar 2022 | - | -$34.46 M(-10.6%) | -$128.65 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$118.05 M(+166.6%) | -$38.55 M(+31.6%) | -$118.05 M(+23.2%) |
| Sep 2021 | - | -$29.28 M(+11.0%) | -$95.80 M(+22.8%) |
| Jun 2021 | - | -$26.37 M(+10.5%) | -$77.98 M(+25.8%) |
| Mar 2021 | - | -$23.86 M(+46.4%) | -$61.98 M(+40.0%) |
| Dec 2020 | -$44.28 M(+155.5%) | -$16.29 M(+42.1%) | -$44.28 M(+30.1%) |
| Sep 2020 | - | -$11.47 M(+10.6%) | -$34.03 M(+22.5%) |
| Jun 2020 | - | -$10.37 M(+68.6%) | -$27.77 M(+30.3%) |
| Mar 2020 | - | -$6.15 M(+1.7%) | -$21.31 M(+22.9%) |
| Dec 2019 | -$17.33 M(+65.1%) | -$6.05 M(+16.2%) | -$17.33 M(+53.6%) |
| Sep 2019 | - | -$5.21 M(+33.3%) | -$11.29 M(+85.6%) |
| Jun 2019 | - | -$3.90 M(+79.6%) | -$6.08 M(+179.6%) |
| Mar 2019 | - | -$2.17 M | -$2.17 M |
| Dec 2018 | -$10.50 M | - | - |
FAQ
- What is Avidity Biosciences annual operating income?
- What is the all time high annual operating profit for Avidity Biosciences?
- What is Avidity Biosciences annual operating profit year-on-year change?
- What is Avidity Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Avidity Biosciences?
- What is Avidity Biosciences quarterly operating profit year-on-year change?
- What is Avidity Biosciences TTM operating income?
- What is the all time high TTM operating profit for Avidity Biosciences?
- What is Avidity Biosciences TTM operating profit year-on-year change?
What is Avidity Biosciences annual operating income?
The current annual operating profit of RNA is -$378.94 M
What is the all time high annual operating profit for Avidity Biosciences?
Avidity Biosciences all-time high annual operating income is -$10.50 M
What is Avidity Biosciences annual operating profit year-on-year change?
Over the past year, RNA annual operating income has changed by -$143.34 M (-60.84%)
What is Avidity Biosciences quarterly operating income?
The current quarterly operating profit of RNA is -$120.99 M
What is the all time high quarterly operating profit for Avidity Biosciences?
Avidity Biosciences all-time high quarterly operating income is -$2.17 M
What is Avidity Biosciences quarterly operating profit year-on-year change?
Over the past year, RNA quarterly operating income has changed by -$22.86 M (-23.29%)
What is Avidity Biosciences TTM operating income?
The current TTM operating profit of RNA is -$378.94 M
What is the all time high TTM operating profit for Avidity Biosciences?
Avidity Biosciences all-time high TTM operating income is -$2.17 M
What is Avidity Biosciences TTM operating profit year-on-year change?
Over the past year, RNA TTM operating income has changed by -$54.25 M (-16.71%)